C12Y 304/21036
Pancreatic elastase
Official title: Pancreatic elastase (3.4.21.36)
C12Y304/21036 (Pancreatic elastase) appears on 10 US grants and 30 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 30
- Assignees
- 9
- Inventors
- 36
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 3 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 0 | 4 |
| 2019 | 2 | 2 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 4 |
| 2024 | 1 | 2 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified porcine pancreatic elastase proteins6 Jan 2026US 12,516,307 B2Onchilles Pharma, Inc.
- Substituted imidazoles for preventing and/or treating cell or tissue necrosis2 Apr 2024US 11,945,787 B2Ela Pharma Ltd.
- Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis28 Dec 2021US 11,207,282 B2Indiana University Research and Technology Corporation
- Substituted thiazoles for preventing and/or treating cell or tissue necrosis6 Apr 2021US 10,968,185 B2Ela Pharma Ltd.
- Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis10 Mar 2020US 10,583,104 B2Indiana University Research and Technology Corporation
- Pharmaceutical compositions comprising protein complexes13 Aug 2026US 2026/0232818 A1Onchilles Pharma, Inc.
- Non-animal based protein sources with functional properties19 Mar 2026US 2026/0078168 A1Clara Foods Co.
- Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto11 Sep 2025US 2025/0282740 A1Ela Pharma Ltd.
- Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto5 Sep 2024US 2024/0294480 A1Ela Pharma Ltd.
- Cartilage treatment for use in eyelid reconstruction27 Jun 2024US 2024/0207484 A1The Regents of the University of California
Most cited
By later US patents
- Human pancreatic elastase12US 5,212,068 ASankyo Company, Limited · 1993
- Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis5US 10,583,104 B2Indiana University Research and Technology Corporation · 2020
- Recombinant elastase proteins and methods of manufacturing and use thereof2US 8,501,449 B2Proteon Therapeutics, Inc. · 2013
- Recombinant elastase proteins and methods of manufacturing and use thereof2US 9,057,060 B2Proteon Therapeutics, Inc. · 2015